Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bokan (Sremska Kamenica, Republic of Serbia), M. Jovancevic Drvenica (Sremska Kamenica, Republic of Serbia), T. Kovacevic (Sremska Kamenica, Republic of Serbia), B. Zaric (Sremska Kamenica, Republic of Serbia), S. Hromis (Sremska Kamenica, Republic of Serbia), B. Zvezdin (Sremska Kamenica, Republic of Serbia), I. Kopitovic (Sremska Kamenica, Republic of Serbia), I. Andrijevic (Sremska Kamenica, Republic of Serbia), B. Perin (Sremska Kamenica, Republic of Serbia), P. Bamidis (Thessaloniki, Greece). The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients. 1235

Member's Comments

No comment yet.

Related content which might interest you: The impact of smoking cessation on respiratory symptoms in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 391s Year: 2005 The cost-effectiveness of antidepressants for smoking cessation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006 COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Introductory lecture: Nicotine addiction treatment in COPD patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006 Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 Smoking cessation and COPD Source: Eur Respir Rev 2013; 22: 37-43 Year: 2013 The influence of smoking on hydrolipoperoxidation in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 306s Year: 2003 Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012 The value of behavioral regulation in patients with bronchial asthma in case of smoking cessation Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation Year: 2019 Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Smoking cessation among COPD and asthma patients: burden vs. motivation Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018 Smoking cessation in asthma patients Source: International Congress 2017 – PG14 Smoking cessation in patients with respiratory diseases Year: 2017 Pharmacological treatment for smoking cessation on COPD smokers Source: Annual Congress 2011 - PG19 How to set up and deliver a smoking cessation service in a pulmonology department Year: 2011 The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007 The respiration status in smokers with chronic bronchitis during smoking cessation period Source: Eur Respir J 2002; 20: Suppl. 38, 328s Year: 2002 Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Smoking habit and psychological status in patients with asthma Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006